The Scottish Government’s Aviation Statement, which will be published shortly, will set out actions that the Scottish Government will take to help achieve our aviation emissions reduction targets. Our Hydrogen Innovation Scheme previously provided £150,000 of funding to Glasgow Airport for a study to explore the feasibility of a hydrogen production, storage and distribution hub that would support zero emission transport at the airport. The Scottish Government has also provided grant funding to Edinburgh Airport to support its low carbon energy system.

Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

The Scottish Government has had no recent discussions with the UK Government regarding Port of Cairnryan Ltd’s submission of company accounts for the year to 31 December 2022.

In the context of specialist provision of gender identity healthcare to children and young people, since publication of its Strategic Action Framework for Gender Identity Service improvement in December 2021, the Scottish Government has maintained an extensive dialogue with NHS Health Boards in Scotland on how to collectively work to improve healthcare provision in this sphere.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

The term “puberty-suppressing hormones” is non-specific, and could be applied to a range of medicines used for a variety of conditions.

The Scottish Government and NHS Scotland are proactively engaged with NHS England and its commissioned research study on puberty-suppressing hormones as a treatment option for gender dysphoria. This is being delivered by the National Institute for Health Research (NIHR). The Scottish Government and the NHS in Scotland are currently observers to that ongoing study development process, however consideration by NHS partners of what further engagement with this study may be appropriate is ongoing, as the scope of the research continues to be developed and defined by NIHR.

Parliamentary business is a matter for the Scottish Parliament’s Parliamentary Bureau and the Parliament itself.

The Scottish Government’s Aviation Statement, which will be published shortly, will set out actions that the Scottish Government will take to help achieve our aviation emissions reduction targets. As noted in the Climate Change Committee’s report, aviation decarbonisation will require UK-wide co-operation and progress across all aviation emissions mitigation solutions.

The Scottish Government is not responsible for the assessment of abandoned calls to NHS 24 which is an operational matter for the Board. We monitor NHS 24 performance against a number of indicators on a weekly basis.

Calls to the 111 service can be abandoned for a variety of reasons, including callers choosing to end their call after being connected to the automated messaging service and hearing the options available to them. These include accessing self-care advice via NHS Inform, or contacting another area of the health service which may be more appropriate to meet their needs.

The Scottish Government continues to support NHS 24's ongoing work to help reduce abandoned calls, including a recent revision of NHS 24's key performance indicators to better reflect and understand the current demands on the service. This work allows the Service to capture any unmet demand, and any potential risks where callers have made multiple attempts to access 111 without success.

The Scottish Government has commissioned Public Health Scotland (PHS) to collect, collate and publish waiting times for all gender identity clinics within the NHS in Scotland. This work will standardise and make routine reporting of waiting time information for these specialist clinical services. This commission also includes collation of patient cohort data, to help inform future service delivery. This work is ongoing.

The Scottish Government also provided funding in 2021 to NHS Greater Glasgow and Clyde to support the publication of a trans/non-binary specific report as part of a wider Health Needs Assessment it published in May 2022, in partnership with NHS Lothian and PHS. The main report can be accessed here: stor.scot.nhs.uk/bitstream/handle/11289/580332/Final Report %2831 May 2022%29.pdf?sequence=1 and the trans/non-binary specific supplementary report accessed here: Health needs assessment LGBT+ people: Transgender and non-binary supplementary report (scot.nhs.uk) .

Furthermore, the Scottish Government has provided grant funding to the University of Glasgow for a programme of research on long-term health outcomes for those accessing gender identity healthcare in Scotland, to help expand the collective evidence base for this healthcare. This work is in progress, and funding has been awarded to a number of research projects and a PhD post as part of this programme.

NHS Greater Glasgow and Clyde’s Young People’s Gender Service only accepts referrals from individuals residing in Scotland.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.